We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Futura Medical Plc | LSE:FUM | London | Ordinary Share | GB0033278473 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.40 | -1.13% | 35.10 | 35.30 | 35.95 | 36.50 | 34.05 | 36.50 | 302,122 | 13:16:04 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -5.85M | -0.0194 | -18.43 | 107.5M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/9/2022 19:36 | But the FTC and ASA don’t care are what ‘James said’ or the rampers say. As its just a subjective opinion and belief. Where is the objective evidence from any adequately controlled study to substantiate Med3000 is have any effect beyond a placebo? It can’t even be substantiated that its having any effect even beyond what a cooling lubricant/arousal gel would have had in an uncontrolled study. The CAP Code required that objective claims, including medical claims for a CE-marked medical device, be backed by evidence, What standards are applied to evidence? The position taken by the ASA is a tried and tested one which has developed over the course of many years. It reflects the opinion of the wider scientific and academic community, rather than judgements made solely by the ASA. There are many aspects that are taken into consideration when evidence is reviewed and each claim is judged on its merits alongside the evidence presented to support it. Evidence submitted for health claims should normally include at least one adequately controlled experimental human | lbo | |
28/9/2022 18:02 | 'A topical gel, MED3000, is technically a medical device rather than a drug. “It has an excellent safety profile,” James said. Its safety profile was superior to that of tadalafil in a recent Phase 3 study. In addition, a single instance of localized mild penile burning was recorded in 1551 intercourse attempts. “No local side effects were recorded in female partners,” James added. In the FM71 study, MED3000 had a superior safety profile over 5 mg of tadalafil. In that study, 19% of tadalafil recipients had a headache, while 4% of MED3000 users did. Similarly, 4% of the tadalafil arm reported either backache or chest pain, while 0% of MED3000 users did. MED3000 users, however, were more likely to experience nausea. A total of 4% of the MED3000 group reported that symptom compared to no tadalafil recipients. “Aside from side-effects, MED3000 has no potential to cause adverse drug interactions, unlike oral ED drugs,” James said. hxxps://www.drugdisc | petroc | |
27/9/2022 19:41 | They would need to raise a lot more money just to cover all the fines and consumer lawsuits regarding misleading claims. If they make some of the rampers claims without disclaimers and clear label warnings. How long then before someone claims the more serious condition underlying their ED went undiagnosed for up to ‘six months’. Because they followed a label claiming it was ok as it was ‘a clinically proven treatment for ED’. Lawsuits could claim the user didn’t understand the gel was only a placebo that caused a delay in treating the more serious underlying causes of their ED. Med3000 was the placebo in FM57. Therefore Futura had initially believed Med3000 had no therapeutic effect. The FM57 study did not set out to measure the efficacy of Med3000. The ASA and the FTC will therefore consider that its reported effectiveness by Futura was a ‘post-hoc finding’ . FM71 was also an unblinded and uncontrolled study so again cannot substantiate any claim that MED3000 is having any effect beyond a placebo .And so was the Consumer HUT uncontrolled and unblinded. One specialist commentator felt that the clinical effectiveness has not been demonstrated. The absence of an adequate placebo (an inactive topical gel) for highlighted as a limitation by 3 commentators. One commentator said that without it, the clinical effectiveness could be attributed to the placebo effect of rubbing a gel In each of the six cases filed, FTC alleged that the companies not only lacked scientific substantiation for their claims regarding the health benefits of their CBD/CBG products, but also falsely represented that their claims were either scientifically proven or had been confirmed by the U.S. government. Under the proposed orders settling FTC complaints in each of these cases, the companies and their owners are prohibited from making prevention, treatment, or safety claims similar to the ones the companies made about their products about any dietary supplements, foods, and drugs unless they have the human clinical testing to substantiate such claims, and are required to have competent and reliable scientific evidence for any other health-related product claims. Specifically, the testing must be: (1) randomized, double-blind, and placebo-controlled | lbo | |
27/9/2022 19:27 | And will the packaging/leaflet also have a obvious warning its only a medical device placebo gel and has not shown any effect beyond a placebo in an adequately controlled study? LOL A product that contemporary technology does not understand must establish that this ‘Magic’ actually works. Proof is what separates an effect new to science from a swindle . . . . If a condition responds to treatment, then selling a placebo as if it had therapeutic effect directly injures the consumer. FTC v. QT, Inc., 512 F.3d 858, 862-63 (7th Cir. Trinity Research even openly admitted the hypothesised effects ˜believed&rsqu Trinity research: Presumably the effect is comparable to the cold-induced vasodilation (CIVD) that occurs with extremities such as toes and fingers. Despite being a well-known effect, the mechanisms of CIVD are still disputed, but the pathways involved could well be similar. Interestingly, the precise mechanism of action does not need to be elucidated for the regulators to be comfortable for a product to be approved as medical device There is no evidence for the evaporative mode of action from the clinical trials. To show that the evaporation is what makes MED3000 work, you'd need to compare it to a non-evaporative gel | lbo | |
27/9/2022 19:11 | Don't worry your ugly big head about MED3000 masking other conditions like the blue pills do, LiarBO. The Eroxon websites states 'If you have a medical condition you may need to speak to a doctor to discuss your condition to see if Eroxon® is suitable for you to use. Eroxon® will come with a leaflet, part of which will cover warnings and precautions and recommend users have a check-up with their doctor as soon as possible within the first 6 months of using Eroxon® to ensure that any erection problems are not caused by another serious health condition.' There, that should allay your fears. | petroc | |
24/9/2022 13:07 | Glad you agree that MED3000 works, LiarBO. Does it feel better now that you've finally admitted it? | petroc | |
24/9/2022 11:29 | ROFLMAO petroc - 18 Sep 2022 - 14:23:27 - 13419 of 13486 Glad to see you've remembered your instructions, LiarBO. When I say jump, you say how high? It seems its actually I who says jump and you say how high. Like the data you are easily manipulated!!! LOL So on the record you are now calling all these respected and impressive organisations like the SMSNA, the FTC, the ASA and EU Courts all fools for applying the required scientific standards to substantiate an effect beyond placebo? | lbo | |
24/9/2022 11:25 | Because LiarBO will go back and delete his comment before everyone sees his stupidity, I've copied it for eternity! 'What are ‘august organisations’ | petroc | |
23/9/2022 22:09 | The only thing ‘ridiculous&rs Med3000 was the placebo in FM57. Therefore Futura had initially believed Med3000 had no therapeutic effect. The FM57 study did not set out to measure the efficacy of Med3000. The ASA and the FTC will therefore consider that its reported effectiveness by Futura was a ˜post-hoc finding’ . FM71 was also an unblinded and uncontrolled study so again cannot substantiate any claim that MED3000 is having any effect beyond a placebo .And so was the Consumer HUT uncontrolled and unblinded. One specialist commentator felt that the clinical effectiveness has not been demonstrated. The absence of an adequate placebo (an inactive topical gel) for highlighted as a limitation by 3 commentators. One commentator said that without it, the clinical effectiveness could be attributed to the placebo effect of rubbing a gel In each of the six cases filed, FTC alleged that the companies not only lacked scientific substantiation for their claims regarding the health benefits of their CBD/CBG products, but also falsely represented that their claims were either scientifically proven or had been confirmed by the U.S. government. Under the proposed orders settling FTC complaints in each of these cases, the companies and their owners are prohibited from making prevention, treatment, or safety claims similar to the ones the companies made about their products about any dietary supplements, foods, and drugs unless they have the human clinical testing to substantiate such claims, and are required to have competent and reliable scientific evidence for any other health-related product claims. Specifically, the testing must be: (1) randomized, double-blind, and placebo-controlled | lbo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions